18 results with keyword: 'future glucose lowering drugs for type diabetes'
Plasma concentrations of FGF21 are raised in obesity and type 2 diabetes, possibly due to FGF21 resistance, and preliminary animal and human studies suggest that administration
N/A
Suggested uses • Clear symptoms of insulin deficiency • Failure of oral agents • Metformin intolerance • Alternate to sulphonylurea if metformin- sulphonylura combination
N/A
• Type 2 diabetes can sometimes be treated with diet and exercise alone, sometimes with oral blood glucose lowering drugs and if this fails to reduce blood glucose
N/A
controlled trials, weight loss with exenatide QW treatment was similar to that of exenatide twice daily or metformin; significantly greater than that of sitagliptin,
N/A
The present study shows that sitagliptin added to existing glucose-lowering drugs is well tolerated, weight- neutral, and improves glycemic control in patients with type 2
N/A
• In this observational study of people with type 2 diabetes with suboptimal glycaemic control using oral glucose-lowering drugs and ⁄ or lifestyle therapy, significant improvements
N/A
We estimated persistence and adherence levels to new glucose-lowering drugs (GLDs) in type 2 diabetes mellitus (T2DM) patients using different methods: through the collection of
N/A
Abstract: Type 2 diabetes carries a risk for hypoglycemia, particularly in patients on an intensive glucose control plan as a glucose-lowering strategy, where
N/A
The album, along with its counterpart Piano Improvisations Vol. 1, was recorded over the course of two days in Oslo, Norway. The two albums in the Piano Improvisations series serve as
N/A
Even though controlling your weight with lifestyle changes is challenging, it produces long-term health rewards by lowering your risk for type 2 diabetes, lowering your blood
N/A
Several key points in this part are: (1) One may accomplish disaster risk reduction which in the medium to long run is not sustainable in terms of ecological, economic,
N/A
The balance of activities requires the glucose-lowering effect of GLP-1 to predominate over the potential for glucagon to raise blood glucose, while effects mediated through
N/A
Even though controlling weight with lifestyle changes is challenging, it produces long- term health rewards by lowering the risk for type 2 diabetes, lowering blood glucose
N/A
These agents are useful in the treatment of patients who have type 2 diabetes but who cannot be managed by diet alone. Patients who have developed diabetes after age
N/A
Also Sulfonylurea dose reduction, in the diabetic patients during fasting, does not cause significant differences in reducing hypoglycemia risk; and on the other hand,
N/A
Full Island buyout nightly rates start from US$36,300 (rate varies, subject to seasonality), inclusive of speedboat transfers from the international airport in Malé for all
N/A
This study aims to determine the prevalence of diabetes in Norwegian nursing homes, and investigate the use of blood glucose lowering drugs, frequency of capillary blood
N/A